Annual long term liabilities:
$202.00K-$8.61M(-97.71%)Summary
- As of today (May 29, 2025), NAMS annual total long term liabilities is $202.00 thousand, with the most recent change of -$8.61 million (-97.71%) on December 31, 2024.
- During the last 3 years, NAMS annual long term liabilities has risen by +$76.30 thousand (+60.70%).
- NAMS annual long term liabilities is now -98.37% below its all-time high of $12.37 million, reached on December 31, 2022.
Performance
NAMS Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$137.00K-$65.00K(-32.18%)Summary
- As of today (May 29, 2025), NAMS quarterly total long term liabilities is $137.00 thousand, with the most recent change of -$65.00 thousand (-32.18%) on March 31, 2025.
- Over the past year, NAMS quarterly long term liabilities has dropped by -$16.80 million (-99.19%).
- NAMS quarterly long term liabilities is now -99.28% below its all-time high of $19.07 million, reached on September 30, 2024.
Performance
NAMS quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NAMS Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.7% | -99.2% |
| 3 y3 years | +60.7% | -98.3% |
| 5 y5 years | +100.0% | +9.0% |
NAMS Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.4% | +60.7% | -99.3% | +9.0% |
| 5 y | 5-year | -98.4% | >+9999.0% | -99.3% | +9.0% |
| alltime | all time | -98.4% | >+9999.0% | -99.3% | +9.0% |
NAMS Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $137.00K(-32.2%) |
| Dec 2024 | $202.00K(-97.7%) | $202.00K(-98.9%) |
| Sep 2024 | - | $19.07M(+36.8%) |
| Jun 2024 | - | $13.94M(-17.7%) |
| Mar 2024 | - | $16.93M(+92.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $8.81M(-28.8%) | $8.81M(-22.8%) |
| Jun 2023 | - | $11.41M(-7.8%) |
| Dec 2022 | $12.37M(+9744.1%) | $12.37M(+57.3%) |
| Jun 2022 | - | $7.87M(+6157.6%) |
| Dec 2021 | $125.70K(>+9900.0%) | $125.70K |
| Dec 2020 | $0.00 | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total long term liabilities?
- What is the all time high annual long term liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual long term liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly long term liabilities year-on-year change?
What is NewAmsterdam Pharma Company NV annual total long term liabilities?
The current annual long term liabilities of NAMS is $202.00K
What is the all time high annual long term liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total long term liabilities is $12.37M
What is NewAmsterdam Pharma Company NV annual long term liabilities year-on-year change?
Over the past year, NAMS annual total long term liabilities has changed by -$8.61M (-97.71%)
What is NewAmsterdam Pharma Company NV quarterly total long term liabilities?
The current quarterly long term liabilities of NAMS is $137.00K
What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total long term liabilities is $19.07M
What is NewAmsterdam Pharma Company NV quarterly long term liabilities year-on-year change?
Over the past year, NAMS quarterly total long term liabilities has changed by -$16.80M (-99.19%)